PetMed Express (NASDAQ:PETS) Shares Pass Above 200-Day Moving Average – Time to Sell?

PetMed Express, Inc. (NASDAQ:PETS) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $4.14 and traded as high as $4.93. PetMed Express shares last traded at $4.64, with a volume of 345,642 shares traded.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded PetMed Express from a “hold” rating to a “buy” rating in a report on Tuesday, November 12th.

PetMed Express Trading Down 3.7 %

The stock has a market capitalization of $95.88 million, a price-to-earnings ratio of -77.33 and a beta of 0.71. The business has a 50 day simple moving average of $4.96 and a 200-day simple moving average of $4.14.

PetMed Express (NASDAQ:PETS) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.11 earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.17. PetMed Express had a negative net margin of 0.37% and a negative return on equity of 1.00%. The business had revenue of $59.57 million for the quarter, compared to analyst estimates of $66.02 million. Research analysts predict that PetMed Express, Inc. will post 0.24 EPS for the current year.

Insiders Place Their Bets

In other news, Director Leslie C.G. Campbell purchased 15,000 shares of the stock in a transaction on Wednesday, December 4th. The stock was purchased at an average price of $5.38 per share, with a total value of $80,700.00. Following the completion of the transaction, the director now owns 70,000 shares in the company, valued at approximately $376,600. The trade was a 27.27 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 1.10% of the stock is currently owned by insiders.

Hedge Funds Weigh In On PetMed Express

Hedge funds and other institutional investors have recently modified their holdings of the company. Point72 DIFC Ltd acquired a new stake in PetMed Express during the 2nd quarter worth approximately $34,000. Marshall Wace LLP acquired a new position in PetMed Express during the second quarter valued at approximately $46,000. Independent Advisor Alliance purchased a new stake in PetMed Express during the third quarter worth approximately $106,000. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of PetMed Express in the second quarter worth $135,000. Finally, Sei Investments Co. increased its position in shares of PetMed Express by 8.3% in the second quarter. Sei Investments Co. now owns 44,220 shares of the company’s stock worth $179,000 after acquiring an additional 3,400 shares in the last quarter. 73.33% of the stock is owned by institutional investors and hedge funds.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.